Skip to main content

Advertisement

Log in

Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

A simple method for the rapid expansion of human CD4+ T cells with both helper and killer functions was established. CD4+ T cells separated from peripheral blood mononuclear cells using immunomagnetic beads were stimulated with immobilised OKT-3 monoclonal antibody (mAb) plus recombinant interleukin 2 (rIL-2) in 96 well culture plates. After 6 day-culture, the CD4+ T cells were restimulated by immobilised OKT-3 mAb for an additional 24 h, then inoculated into concentrated rotary-tissue culture bag and cultured for further 9 days. This procedure yielded a 3000-fold increase in cell number (about 3-5 x 10(9) per bag). Most of the cells (over 96%) continued to express CD4+ antigen and retained their capacity to produce IL-2. The activated CD4+ T cells showed marked cytotoxicity against Fc receptor positive tumour cells in the presence of OKT-3 mAb. Moreover, we succeeded in a specific targeting of the expanded CD4+ helper/killer T cells to c-erb B-2 positive tumour cells by means of anti-CD3 x anti-c-erb B-2 bispecific antibody. These results suggested that our established simple system will be available for the expansion of large number of CD4+ helper/killer T cells which may provide an efficient strategy for adoptive tumour immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, Y., Tokuda, Y., Iwasawa, M. et al. Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy. Br J Cancer 66, 20–26 (1992). https://doi.org/10.1038/bjc.1992.210

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1992.210

  • Springer Nature Limited

This article is cited by

Navigation